Calprotectin predicts relaps after stopping TNFα treatment
Molander et al. investigated if concentrations of fecal calprotectin can be used for predicting relaps after stopping TNFα blocking therapy in patients with Ulcerative Colitis and Morbus Crohn. The...
View ArticleInflammatory Bowel Disease – TNFalpha Blocker Treatment and Calprotectin
Chronic inflammatory bowel disease (IBD) is characterized by recurring and often ongoing flares. The most common forms of IBD are Crohns disease and Ulcerative colitis. Stopping the inflammatory cycle...
View Article
More Pages to Explore .....
